{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:05:27Z","timestamp":1751515527018,"version":"3.41.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.mehy.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T17:16:51Z","timestamp":1520270211000},"page":"35-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Left ventricular hypertrophy as protective factor after bypass grafting"],"prefix":"10.1016","volume":"114","author":[{"given":"Gian Luca","family":"Iannuzzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-9921","authenticated-orcid":false,"given":"Mauro","family":"Maniscalco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Scognamiglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Furgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Rengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2018.03.003_b0005","first-page":"194","article-title":"Assessment of left ventricular systolic function in patients with iron deficiency anemia by three-dimensional speckle-tracking echocardiography","volume":"18","author":"Zhou","year":"2017","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.mehy.2018.03.003_b0010","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.amjms.2017.05.015","article-title":"Left ventricular false tendons are associated with left ventricular dilation and impaired systolic and diastolic function","volume":"354","author":"Hall","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.mehy.2018.03.003_b0015","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1080\/14779072.2016.1186542","article-title":"Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic","volume":"14","author":"Cramariuc","year":"2016","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.mehy.2018.03.003_b0020","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2018.03.003_b0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ccep.2015.03.017","article-title":"Left ventricular hypertrophy and arrhythmogenesis","volume":"7","author":"Shenasa","year":"2015","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.mehy.2018.03.003_b0030","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.amjcard.2014.07.015","article-title":"Meta-analysis of left ventricular hypertrophy and sustained arrhythmias","volume":"114","author":"Chatterjee","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2018.03.003_b0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/ejechocard\/jer176","article-title":"Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography\/European Association of Echocardiography","volume":"13","author":"Barbieri","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.mehy.2018.03.003_b0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.31053\/1853.0605.v71.n4.11057","article-title":"Association of systolic dysfunction with left ventricular hypertrophy and diastolic dysfunction in hypertensive patients","volume":"71","author":"Piskorz","year":"2014","journal-title":"Rev Fac Cien Med Univ Nac Cordoba"},{"key":"10.1016\/j.mehy.2018.03.003_b0045","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1139\/cjpp-2014-0236","article-title":"Functional contribution of alpha1D-adrenoceptors in the renal vasculature of left ventricular hypertrophy induced with isoprenaline and caffeine in Wistar-Kyoto rats","volume":"92","author":"Ahmad","year":"2014","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.mehy.2018.03.003_b0050","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003959","article-title":"Association of concentric left ventricular hypertrophy with subsequent change in left ventricular end-diastolic volume: the dallas heart study","volume":"10","author":"Garg","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.mehy.2018.03.003_b0055","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/08037051.2016.1179514","article-title":"Relationship of diastolic function to new or persistent electrocardiographic left ventricular hypertrophy","volume":"25","author":"Tanoue","year":"2016","journal-title":"Blood Press"},{"key":"10.1016\/j.mehy.2018.03.003_b0060","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/CIRCULATIONAHA.117.028441","article-title":"Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: SPRINT (systolic blood pressure intervention trial)","volume":"136","author":"Soliman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.03.003_b0065","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1161\/CIRCULATIONAHA.114.011085","article-title":"Left ventricular hypertrophy with strain and aortic stenosis","volume":"130","author":"Shah","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.03.003_b0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13244-017-0549-2","article-title":"Utility of magnetic resonance imaging in the evaluation of left ventricular thickening","volume":"8","author":"Fulton","year":"2017","journal-title":"Insights Imaging"},{"key":"10.1016\/j.mehy.2018.03.003_b0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.mehy.2018.03.003_b0080","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCRESAHA.116.308688","article-title":"Deletion of interleukin-6 attenuates pressure overload-induced left ventricular hypertrophy and dysfunction","volume":"118","author":"Zhao","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.mehy.2018.03.003_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC heart failure long-term registry","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.mehy.2018.03.003_b0090","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/CIRCRESAHA.116.304723","article-title":"The epidemiology of blood pressure and its worldwide management","volume":"116","author":"Rahimi","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.mehy.2018.03.003_b0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijcard.2017.03.002","article-title":"Hypertension, left ventricular hypertrophy, and sudden cardiac death","volume":"237","author":"Shenasa","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.mehy.2018.03.003_b0100","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005948","article-title":"Impact of chamber dilatation on the prognostic value of left ventricular geometry in hypertension","volume":"6","author":"Verdecchia","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.mehy.2018.03.003_b0105","article-title":"Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients","volume":"7","author":"Bang","year":"2014","journal-title":"Circulat Cardiovasc Imag"},{"key":"10.1016\/j.mehy.2018.03.003_b0110","first-page":"344","article-title":"Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function","volume":"16","author":"Yakar Tuluce","year":"2016","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.mehy.2018.03.003_b0115","article-title":"Influence of left atrial function on exercise capacity and left ventricular function in patients with heart failure and preserved ejection fraction","volume":"10","author":"von Roeder","year":"2017","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.mehy.2018.03.003_b0120","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2018.03.003_b0125","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jex189","article-title":"Left ventricular global longitudinal strain is predictive of all-cause mortality independent of aortic stenosis severity and ejection fraction","author":"Ng","year":"2017","journal-title":"Eur Heart J Cardiovasc Imag"},{"key":"10.1016\/j.mehy.2018.03.003_b0130","article-title":"Heart failure with recovered ejection fraction: clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry","author":"Agra Bermejo","year":"2017","journal-title":"Cardiol J"},{"key":"10.1016\/j.mehy.2018.03.003_b0135","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1161\/CIRCULATIONAHA.111.070235","article-title":"Advances in the epidemiology of heart failure and left ventricular remodeling","volume":"124","author":"Cheng","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.03.003_b0140","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCIMAGING.113.001275","article-title":"Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients","volume":"7","author":"Bang","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.mehy.2018.03.003_b0145","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/CIRCULATIONAHA.109.865774","volume":"120","author":"Verdecchia","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.03.003_b0150","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/10641963.2016.1267196","article-title":"Association of renin-angiotensin-aldosterone system gene polymorphisms with left ventricular hypertrophy in patients with heart failure with preserved ejection fraction: a case-control study","volume":"39","author":"Bahramali","year":"2017","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.mehy.2018.03.003_b0155","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.CIR.103.2.226","article-title":"Left ventricular hypertrophy with exercise and ACE gene insertion\/deletion polymorphism: a randomized controlled trial with losartan","volume":"103","author":"Myerson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.03.003_b0160","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/CIRCULATIONAHA.108.826214","article-title":"Aliskiren in left ventricular hypertrophy trial I: effect of the direct renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy","volume":"119","author":"Solomon","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.03.003_b0165","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1177\/2047487317721644","article-title":"Factors associated with global longitudinal strain decline in hypertensive patients with normal left ventricular ejection fraction","volume":"24","author":"Soufi Taleb Bendiab","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.mehy.2018.03.003_b0170","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jdiacomp.2017.06.014","article-title":"Left ventricular mass, geometry and function in diabetic patients affected by coronary artery disease","volume":"31","author":"Maiello","year":"2017","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.mehy.2018.03.003_b0175","doi-asserted-by":"crossref","first-page":"e0172280","DOI":"10.1371\/journal.pone.0172280","article-title":"Prognostic value of dobutamine stress myocardial perfusion echocardiography in patients with known or suspected coronary artery disease and normal left ventricular function","volume":"12","author":"Mattoso","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2018.03.003_b0180","first-page":"296","article-title":"Poststress left ventricular ejection fraction is an independent predictor of major cardiac events in patients with coronary artery disease and impaired left ventricular function","volume":"52","author":"De Winter","year":"2008","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.mehy.2018.03.003_b0185","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1161\/01.CIR.0000147184.13872.0F","article-title":"Alterations of left ventricular myocardial characteristics associated with obesity","volume":"110","author":"Wong","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.03.003_b0190","article-title":"Longitudinal two-dimensional strain for the diagnosis of left ventricular segmental dysfunction in patients with acute myocardial infarction","author":"Eitan","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.mehy.2018.03.003_b0195","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.amjcard.2017.06.006","article-title":"Comparison of left ventricular function and myocardial infarct size determined by 2-dimensional speckle tracking echocardiography in patients with and without chronic obstructive pulmonary disease after ST-segment elevation myocardial infarction","volume":"120","author":"Goedemans","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2018.03.003_b0200","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.7863\/ultra.15.09032","article-title":"Assessment of left ventricular myocardial viability by 3-dimensional speckle-tracking echocardiography in patients with myocardial infarction","volume":"35","author":"Ran","year":"2016","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.mehy.2018.03.003_b0205","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/hc1002.105185","article-title":"Progression of systolic abnormalities in patients with \u201cisolated\u201d diastolic heart failure and diastolic dysfunction","volume":"105","author":"Yu","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.03.003_b0210","article-title":"Left ventricular dysfunction causing ischemia in patients with patent coronary arteries","author":"Nguyen","year":"2017","journal-title":"Perfusion"},{"key":"10.1016\/j.mehy.2018.03.003_b0215","article-title":"Improvement of left ventricular diastolic function and left heart morphology in young women with morbid obesity six months after bariatric surgery","author":"Kurnicka","year":"2017","journal-title":"Cardiol J"},{"key":"10.1016\/j.mehy.2018.03.003_b0220","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure\u2013abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2018.03.003_b0225","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jacc.2013.09.052","article-title":"Impaired systolic function by strain imaging in heart failure with preserved ejection fraction","volume":"63","author":"Kraigher-Krainer","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2018.03.003_b0230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurjhf\/hfq121","article-title":"Epidemiology and clinical course of heart failure with preserved ejection fraction","volume":"13","author":"Lam","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.mehy.2018.03.003_b0235","first-page":"70","article-title":"Reply: electrocardiographic criteria for diagnosing left ventricular hypertrophy and predicting mortality in patients with aortic stenosis","volume":"2017","author":"Peguero","year":"1832","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2018.03.003_b0240","article-title":"LV mass independently predicts mortality and need for future revascularization in patients undergoing diagnostic coronary angiography","author":"Abdi-Ali","year":"2017","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.mehy.2018.03.003_b0245","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/CIRCULATIONAHA.105.574822","article-title":"Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study","volume":"113","author":"Okin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.03.003_b0250","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/hrt.2004.042473","article-title":"Left ventricular hypertrophy in hypertension: its arrhythmogenic potential","volume":"91","author":"Kahan","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.mehy.2018.03.003_b0255","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIRCRESAHA.116.304555","article-title":"Clinical management and prevention of sudden cardiac death","volume":"116","author":"Yousuf","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.mehy.2018.03.003_b0260","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/CIRCULATIONAHA.111.089425","article-title":"Implantable cardioverter-defibrillators have reduced the incidence of resuscitation for out-of-hospital cardiac arrest caused by lethal arrhythmias","volume":"126","author":"Hulleman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.03.003_b0265","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/CIRCULATIONAHA.111.086983","article-title":"Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of fallot","volume":"125","author":"Diller","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.03.003_b0270","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/pace.12426","article-title":"Left ventricular hypertrophy and antiarrhythmic drugs in atrial fibrillation: impact on mortality","volume":"37","author":"Chung","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.mehy.2018.03.003_b0275","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10554-017-1103-5","article-title":"Contribution of mitral valve leaflet length and septal wall thickness to outflow tract obstruction in patients with hypertrophic cardiomyopathy","volume":"33","author":"Morant","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.mehy.2018.03.003_b0280","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.03.003_b0285","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2018.03.003_b0290","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/echo.12825","article-title":"Combined circumferential and longitudinal left ventricular systolic dysfunction in patients with asymptomatic aortic stenosis","volume":"32","author":"Cioffi","year":"2015","journal-title":"Echocardiography"},{"key":"10.1016\/j.mehy.2018.03.003_b0295","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10554-016-0858-4","article-title":"Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography","volume":"32","author":"Corona-Villalobos","year":"2016","journal-title":"Int J Cardiovasc Imaging"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717311325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717311325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T10:22:12Z","timestamp":1751451732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987717311325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":59,"alternative-id":["S0306987717311325"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2018.03.003","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left ventricular hypertrophy as protective factor after bypass grafting","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}